Glucocorticoid-Induced Osteoporosis: A Patient Guide
At a Glance
Steroid medicines such as prednisone or dexamethasone can weaken bones within months, often without symptoms. Early risk assessment using a clinical review, DXA bone-density scan, spine imaging, and an adjusted FRAX score helps guide treatment to prevent fractures.
Glucocorticoid-Induced Osteoporosis (GIOP) is a condition where bones become fragile and prone to breaking as a direct result of taking steroid medications like prednisone or dexamethasone. While these medications are often vital for controlling serious inflammation or autoimmune diseases, they can rapidly change the way your body maintains its skeleton. Unlike age-related bone loss, which happens gradually over decades, GIOP can weaken the internal structure of your bones within just a few months of starting treatment [1][2].
The primary challenge of GIOP is that it is often “silent,” meaning you cannot feel your bones getting weaker. Steroids cause a “double hit” by simultaneously speeding up the breakdown of old bone and slowing down the production of new bone cells [3]. This rapid damage often leads to fractures—particularly in the spine—at bone density levels that might be considered normal in other people. Because these spinal fractures can happen without a sudden injury or dramatic pain, they are easily overlooked unless a medical team is specifically looking for them [4][5].
Accurately assessing your risk requires more than just a standard bone density (DXA) scan. Because steroids degrade the quality of the bone’s internal architecture, a simple density measurement may underestimate how likely a person is to suffer a fracture. A complete evaluation relies on the clinician’s assessment based on age and clinical risk. This typically includes a clinical evaluation, a DXA scan, and often a Vertebral Fracture Assessment (VFA) or spinal imaging. For adults aged 40 and older, clinicians apply a dose-adjusted correction to the FRAX score to get a clearer picture of your risk [1][6]. Using these tools early—ideally when you first start your steroids—allows your care team to move from reacting to damage to actively preventing it.
Fortunately, modern medicine offers several ways to protect your skeleton. Effective treatments exist that can either lock in your existing bone strength or stimulate your body to build new, healthy bone [1][7]. Managing your bone health is a collaborative effort that happens alongside the treatment of your underlying condition. By coordinating with your specialists and staying proactive with your monitoring, you can continue the steroid therapy you need to stay well while ensuring your bones are protected and your mobility is prioritized [8].
Disclaimer: This guide is intended for adult patients. Children, pregnant or breastfeeding patients, and individuals with severe kidney disease should seek individualized specialist advice. This guide supports—but does not replace—individual medical advice. Do not change glucocorticoid or osteoporosis medication doses independently.
In this guide
7 chapters
Understanding Your Diagnosis: Glucocorticoid-Induced Osteoporosis (GIOP)
Learn about glucocorticoid-induced osteoporosis, when steroid use raises fracture risk, and how DXA, FRAX, calcium, vitamin D, and treatment protect bones.
Recognizing the Warning Signs of Bone Weakening
Learn the warning signs of glucocorticoid-induced osteoporosis, including silent vertebral fractures, height loss, back pain, posture changes, and red flags.
Assessing Your Fracture Risk: Beyond Bone Density
Learn how DXA, adjusted FRAX, vertebral imaging, and TBS reveal fracture risk in glucocorticoid-induced osteoporosis, even when bone density looks normal.
Lifestyle & Daily Management: Protecting Your Bones Every Day
Learn how to protect your bones with glucocorticoid-induced osteoporosis through calcium, vitamin D, safe exercise, fall prevention, and steroid-dose planning.
Medical Treatments: Strengthening and Protecting Steroid-Treated Bone
Learn how glucocorticoid-induced osteoporosis is treated, including bisphosphonates, teriparatide, denosumab, sequential therapy, rare risks, and drug holidays.
Building Your Care Team: Coordinating Bone Health and Disease Control
Learn how to build a care team for glucocorticoid-induced osteoporosis, coordinate steroid tapering, prepare for bone visits, and monitor fracture risk safely with your team.
Long-Term Monitoring: Life During and After Steroid Treatment
Learn how to monitor glucocorticoid-induced osteoporosis during and after steroid treatment, including DXA scans, fracture risk, bone markers, and safe activity.
Common questions in this guide
What is glucocorticoid-induced osteoporosis?
Why can steroids cause fractures even when my bone-density result looks normal?
What tests check fracture risk during steroid treatment?
Can steroid-related spinal fractures happen without pain?
Should I start a bone-strengthening medicine when I begin steroids?
How can I protect my bones while I still need steroids?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How does my current steroid dose impact my specific risk of a fracture compared to someone not on steroids?
- 2.Are we using an 'adjusted' FRAX score and vertebral imaging to get the most accurate picture of my bone health?
- 3.Should we start a bone-strengthening medication now to prevent loss, rather than waiting for my next bone density scan?
- 4.Who on my care team will be the primary point of contact for monitoring my bone health long-term?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (8)
- 1
2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.
Humphrey MB, Russell L, Danila MI, et al.
Arthritis & rheumatology (Hoboken, N.J.) 2023; (75(12)):2088-2102 doi:10.1002/art.42646.
PMID: 37845798 - 2
Understanding and Managing Corticosteroid-Induced Osteoporosis.
Kobza AO, Herman D, Papaioannou A, et al.
Open access rheumatology : research and reviews 2021; (13()):177-190 doi:10.2147/OARRR.S282606.
PMID: 34239333 - 3
Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment.
Chotiyarnwong P, McCloskey EV
Nature reviews. Endocrinology 2020; (16(8)):437-447 doi:10.1038/s41574-020-0341-0.
PMID: 32286516 - 4
[Translated article] Approach to the elderly patient with vertebral fracture due to bone fragility.
Hormigo-Sánchez AI, Neira-Álvarez M, Pareja-Sierra T
Revista espanola de cirugia ortopedica y traumatologia 2024; (68(6)):T572-T581 doi:10.1016/j.recot.2024.08.004.
PMID: 39128694 - 5
Management of glucocorticoid-related osteoporotic vertebral fracture.
Wong SPY, Mok CC
Osteoporosis and sarcopenia 2020; (6(1)):1-7 doi:10.1016/j.afos.2020.02.002.
PMID: 32226826 - 6
The impact of glucocorticoid therapy on trabecular bone score in older women.
Paggiosi MA, Peel NF, Eastell R
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2015; (26(6)):1773-80 doi:10.1007/s00198-015-3078-1.
PMID: 25743176 - 7
The efficiency and safety of alendronate versus teriparatide for treatment glucocorticoid-induced osteoporosis: A meta-analysis and systematic review of randomized controlled trials.
Liu ZM, Zhang M, Zong Y, et al.
PloS one 2022; (17(5)):e0267706 doi:10.1371/journal.pone.0267706.
PMID: 35639783 - 8
Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club.
Laurent MR, Goemaere S, Verroken C, et al.
Frontiers in endocrinology 2022; (13()):908727 doi:10.3389/fendo.2022.908727.
PMID: 35757436
This adult guide is for informational purposes only and does not constitute medical advice. Ask a specialist for individualized guidance if you are a child, pregnant or breastfeeding, or have severe kidney disease, and do not change glucocorticoid or osteoporosis medicines without medical advice.
Get notified when new evidence is published on glucocorticoid-induced osteoporosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.